Continuing Medical Education: Genomic Medicine CME 2011: The Future of Genomic Medicine IV: Scripps Health: La Jolla, CA: March 3 - 4, 2011
http://www.cmenetworks.com/cme/11616/1/Continuing-Medical-Education-Genomic-Medicine-CME-2011-The-Future-of-Genomic-Medicine-IV-Scripps-Health-La-Jolla-CA-March-3---4-2011/Page1.html
Scripps Health
Scripps Health is a $1.7 billion, non-profit, community-based health care system in San Diego, Calif. Scripps treats nearly 500,000 patients annually through the dedication of more than 2,600 affiliated physicians and 11,000 employees across five hospital campuses, an ambulatory care network of clinics, physicians’ offices, outpatient centers and home health care services.
By Scripps Health
Published on 06/28/2010
CME Sponsor:
Scripps Health
Location:
Scripps Institution of Oceanography
The Robert Paine Scripps Forum for Science, Society and the Environment
Samuel H. Scripps Auditorium
8610 Kennel Way
La Jolla, CA, 92037
Course Directors/Instructors:
Course Director
Eric J. Topol, MD
Director, Scripps Translational Science Institute
Chief Academic Officer, Scripps Health
Professor of Translational Genomics,
The Scripps Research Institute
The Gary and Mary West Chair of Innovative Medicine
La Jolla, California
Planning Committee
Samuel Levy, PhD
Director of Genomic Sciences
Scripps Translational Science Institute
Scripps Health and The Scripps Research Institute
La Jolla, California
Sarah S. Murray, PhD
Director, Genetics
Scripps Translational Science Institute
Scripps Health and The Scripps Research Institute
La Jolla, California
Nicholas J. Schork, PhD
Director of Research, Scripps Genomic Medicine
Scripps Health
Director of Biostatistics and Bioinformatics
The Scripps Translational Science Institute
Professor, Department of Molecular and Experimental Medicine, The Scripps Research Institute
La Jolla, California
Conference Faculty
Misha Angrist, PhD
Assistant Professor of the Practice
Duke Institute for Genome Sciences & Policy
Duke University
Durham, North Carolina
David R. Bentley, D.Phil., F.Med.Sci.
Vice President and Chief Scientist
Illumina Cambridge
United Kingdom
Cinnamon S. Bloss, PhD
Assistant Professor
Scripps Translational Science Institute
Scripps Health & The Scripps Research Institute
La Jolla, California
Brook Byers
Partner
Kleiner Perkins Caufield & Byers
Menlo Park, California
Dennis A. Carson, MD
Director, Moores Cancer Center
Chugai Pharmaceutical Chair in Cancer
Associate Dean for Health Sciences
University of California, San Diego
La Jolla, California
Aravinda Chakravarti, PhD
Director, Center for Complex Disease Genomics
McKusick-Nathans Institute of Genetic Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland
Glenn Close
Screen and Theater Actress
Kevin Davies, PhD
Chief Editor, Bio-IT World
Author of The $1,000 Genome
Juan Enriquez, BA, MBA
Managing Director, Excel Venture Management
Chairman and CEO, Biotechonomy LLC
Co-founder, Synthetic Genomics Inc.
Boston, Massachusetts
Philippe Froguel, MD, PhD
Professor of Genomic Medicine,
Chair of the Department of Genomics of Common Diseases
School of Public Health Hammersmith Hospital
Imperial College
London, United Kingdom
Stacey Gabriel, PhD
Co-Director, Genetic Sequencing and Analysis Program
Co-Director, Medical and Population Genetics Program
Broad Institute
Cambridge, Massachusetts
Geoffrey S. Ginsburg, MD, PhD
Director, Center for Genomic Medicine
Executive Director, Personalized Medicine
Duke Institute for Genome Sciences & Policy
Durham, North Carolina
Thomas Goetz, MPh
Executive Editor, WIRED Magazine
Author of The Decision Tree: Taking Control of Your Health in the New Era of Personalized Medicine
Hakon Hakonarson, MD, PhD
Director, Center for Applied Genomics
Associate Professor of Pediatrics
Department of Pediatrics and Division of Genetics
The Children’s Hospital of Philadelphia
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
Amy Harmon
Pulitzer Prize-winning National Correspondent
The New York Times
New York, New York
Stephen L. Hauser, MD
Professor and Chair, Department of Neurology
University of California, San Francisco
San Francisco, California
Thomas J. Kipps, MD, PhD
Evelyn and Edwin Tasch Chair in Cancer Research
Professor of Medicine and Deputy Director, Research
Moores UCSD Cancer Center
University of California, San Diego
La Jolla, California
James R. Lupski, MD, PhD
Cullen Professor and Vice Chairman
Molecular and Human Genetics
and Professor of Pediatrics
Baylor College of Medicine
Houston, Texas
Amy Dockser Marcus
Pulitzer Prize-winning Journalist
The Wall Street Journal
Boston, Massachusetts
Elaine R. Mardis, PhD
Associate Professor, Genetics and Molecular Microbiology
Co-Director of The Genome Center
Washington University
Washington University School of Medicine at Washington University Medical Center
St. Louis, Missouri
Mark McCarthy, MD, F.Med.Sci.
Professor, Oxford Centre for Diabetes
Endocrinology and Metabolism
Wellcome Trust Centre for Human Genetics
Oxford, United Kingdom
Karen Mohlke, PhD
Associate Professor, Department of Genetics
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Matthew J. Price, MD, FACC
Director, Cardiac Catheterization Laboratory
Division of Cardiovascular Diseases
Scripps Clinic
La Jolla, California
Daniel J. Rader, MD
Cooper-McClure Professor of Medicine and Pharmacology
Director, Clinical and Translational Research Center Associate Director, Institute of Translational Medicine and Therapeutics
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
Stephen S. Rich, PhD
Director, Center for Public Health Genomics
Harrison Professor of Public Health Sciences
University of Virginia, School of Medicine
Charlottesville, Virginia
Steve Shak, MD
Chief Medical Officer, Genomic Health
Redwood City, California
Kári Stefánsson, MD
Executive Chairman and President of Research
deCODE genetics
Reykjavik, Iceland
Robert L. Strausberg, PhD
Executive Director of Collaborative Sciences
Ludwig Institute for Cancer Research Ltd
New York, New York
Melanie Swan, MBA
Founder, DIYgenomics
Palo Alto, California
Hannah A. Valantine, MD, MRCP, FACC
Senior Associate Dean
Professor of Medicine, Cardiovascular Medicine
Stanford University School of Medicine
Stanford, California
Daniel D. Von Hoff, MD, FACP
Physician-in-Chief, Senior Investigator
Translational Genomics Research Institute
Clinical Professor of Medicine
University of Arizona
Chief Scientific Officer
Scottsdale Healthcare
Phoenix, Arizona
Registration Fee:
Through February 24, 2011: $95
After February 24, 2011: $120
Students, Residents and Fellows:
Through February 24, 2011: waived
After February 24, 2011: $25
More Info
Detailed Description:
The fourth Future of Genomic Medicine conference will focus on the extraordinary advances that are occurring in the field, which include whole genome sequencing, new gene expression tests for routine medical practice, and consumer genomics. The 2011 conference will include in depth sessions on cancer genomics and diabetes, two areas in which there have been particularly remarkable progress. We will feature sessions on “views from the outside” with speakers who are journalists and public figures, not scientists. Our overarching goal is to spearhead efforts to change medicine using genomics.
Learning Objectives:
Intended Audience:
The Future of Genomic Medicine IV
CME Sponsor:
Scripps Health
Location:
Scripps Institution of Oceanography
The Robert Paine Scripps Forum for Science, Society and the Environment
Samuel H. Scripps Auditorium
8610 Kennel Way
La Jolla, CA, 92037
Course Directors/Instructors:
Course Director
Eric J. Topol, MD
Director, Scripps Translational Science Institute
Chief Academic Officer, Scripps Health
Professor of Translational Genomics,
The Scripps Research Institute
The Gary and Mary West Chair of Innovative Medicine
La Jolla, California
Planning Committee
Samuel Levy, PhD
Director of Genomic Sciences
Scripps Translational Science Institute
Scripps Health and The Scripps Research Institute
La Jolla, California
Sarah S. Murray, PhD
Director, Genetics
Scripps Translational Science Institute
Scripps Health and The Scripps Research Institute
La Jolla, California
Nicholas J. Schork, PhD
Director of Research, Scripps Genomic Medicine
Scripps Health
Director of Biostatistics and Bioinformatics
The Scripps Translational Science Institute
Professor, Department of Molecular and Experimental Medicine, The Scripps Research Institute
La Jolla, California
Conference Faculty
Misha Angrist, PhD
Assistant Professor of the Practice
Duke Institute for Genome Sciences & Policy
Duke University
Durham, North Carolina
David R. Bentley, D.Phil., F.Med.Sci.
Vice President and Chief Scientist
Illumina Cambridge
United Kingdom
Cinnamon S. Bloss, PhD
Assistant Professor
Scripps Translational Science Institute
Scripps Health & The Scripps Research Institute
La Jolla, California
Brook Byers
Partner
Kleiner Perkins Caufield & Byers
Menlo Park, California
Dennis A. Carson, MD
Director, Moores Cancer Center
Chugai Pharmaceutical Chair in Cancer
Associate Dean for Health Sciences
University of California, San Diego
La Jolla, California
Aravinda Chakravarti, PhD
Director, Center for Complex Disease Genomics
McKusick-Nathans Institute of Genetic Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland
Glenn Close
Screen and Theater Actress
Kevin Davies, PhD
Chief Editor, Bio-IT World
Author of The $1,000 Genome
Juan Enriquez, BA, MBA
Managing Director, Excel Venture Management
Chairman and CEO, Biotechonomy LLC
Co-founder, Synthetic Genomics Inc.
Boston, Massachusetts
Philippe Froguel, MD, PhD
Professor of Genomic Medicine,
Chair of the Department of Genomics of Common Diseases
School of Public Health Hammersmith Hospital
Imperial College
London, United Kingdom
Stacey Gabriel, PhD
Co-Director, Genetic Sequencing and Analysis Program
Co-Director, Medical and Population Genetics Program
Broad Institute
Cambridge, Massachusetts
Geoffrey S. Ginsburg, MD, PhD
Director, Center for Genomic Medicine
Executive Director, Personalized Medicine
Duke Institute for Genome Sciences & Policy
Durham, North Carolina
Thomas Goetz, MPh
Executive Editor, WIRED Magazine
Author of The Decision Tree: Taking Control of Your Health in the New Era of Personalized Medicine
Hakon Hakonarson, MD, PhD
Director, Center for Applied Genomics
Associate Professor of Pediatrics
Department of Pediatrics and Division of Genetics
The Children’s Hospital of Philadelphia
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
Amy Harmon
Pulitzer Prize-winning National Correspondent
The New York Times
New York, New York
Stephen L. Hauser, MD
Professor and Chair, Department of Neurology
University of California, San Francisco
San Francisco, California
Thomas J. Kipps, MD, PhD
Evelyn and Edwin Tasch Chair in Cancer Research
Professor of Medicine and Deputy Director, Research
Moores UCSD Cancer Center
University of California, San Diego
La Jolla, California
James R. Lupski, MD, PhD
Cullen Professor and Vice Chairman
Molecular and Human Genetics
and Professor of Pediatrics
Baylor College of Medicine
Houston, Texas
Amy Dockser Marcus
Pulitzer Prize-winning Journalist
The Wall Street Journal
Boston, Massachusetts
Elaine R. Mardis, PhD
Associate Professor, Genetics and Molecular Microbiology
Co-Director of The Genome Center
Washington University
Washington University School of Medicine at Washington University Medical Center
St. Louis, Missouri
Mark McCarthy, MD, F.Med.Sci.
Professor, Oxford Centre for Diabetes
Endocrinology and Metabolism
Wellcome Trust Centre for Human Genetics
Oxford, United Kingdom
Karen Mohlke, PhD
Associate Professor, Department of Genetics
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Matthew J. Price, MD, FACC
Director, Cardiac Catheterization Laboratory
Division of Cardiovascular Diseases
Scripps Clinic
La Jolla, California
Daniel J. Rader, MD
Cooper-McClure Professor of Medicine and Pharmacology
Director, Clinical and Translational Research Center Associate Director, Institute of Translational Medicine and Therapeutics
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
Stephen S. Rich, PhD
Director, Center for Public Health Genomics
Harrison Professor of Public Health Sciences
University of Virginia, School of Medicine
Charlottesville, Virginia
Steve Shak, MD
Chief Medical Officer, Genomic Health
Redwood City, California
Kári Stefánsson, MD
Executive Chairman and President of Research
deCODE genetics
Reykjavik, Iceland
Robert L. Strausberg, PhD
Executive Director of Collaborative Sciences
Ludwig Institute for Cancer Research Ltd
New York, New York
Melanie Swan, MBA
Founder, DIYgenomics
Palo Alto, California
Hannah A. Valantine, MD, MRCP, FACC
Senior Associate Dean
Professor of Medicine, Cardiovascular Medicine
Stanford University School of Medicine
Stanford, California
Daniel D. Von Hoff, MD, FACP
Physician-in-Chief, Senior Investigator
Translational Genomics Research Institute
Clinical Professor of Medicine
University of Arizona
Chief Scientific Officer
Scottsdale Healthcare
Phoenix, Arizona
Registration Fee:
Through February 24, 2011: $95
After February 24, 2011: $120
Students, Residents and Fellows:
Through February 24, 2011: waived
After February 24, 2011: $25
More Info
Detailed Description:
The fourth Future of Genomic Medicine conference will focus on the extraordinary advances that are occurring in the field, which include whole genome sequencing, new gene expression tests for routine medical practice, and consumer genomics. The 2011 conference will include in depth sessions on cancer genomics and diabetes, two areas in which there have been particularly remarkable progress. We will feature sessions on “views from the outside” with speakers who are journalists and public figures, not scientists. Our overarching goal is to spearhead efforts to change medicine using genomics.
Learning Objectives:
- Demonstrate the unmet needs of medicine today with respect to more targeted, individualized prevention and treatments
- Discuss the opportunities of the genome, proteome, metabolome discovery to change medical practice as it exists today
- Assess how changes and advances in technology are rapidly ushering in a whole array of new pathways for individualized medicine of the future
- Explore specific strategies in cancer, cardiovascular and pharmacogenomic interventions
Intended Audience:
- Physicians
- Health care professionals of all disciplines interested in the future of medicine, especially with respect to individualized therapies
- Human geneticists
- Genomic scientists
- Researchers